Business Wire: September 13, 2016 – WOBURN, MA, U.S.A. – Aphios Corporation today announced that it plans to continue its research to develop a cure for HIV/AIDS using combination drugs in targeted “nanosomes” nanoparticles with recent funding from the National Institute of Allergy and Infectious…
Business Wire: July 12, 2016 – WOBURN, MA, U.S.A. – Aphios Corporation announced today that it has been awarded a subcontract for the nanoformulation of a superhydrophobic anticancer drug administered through the Frederick National Laboratory for Cancer Research in Frederick, Maryland.
Several…
